Review of India's Covaxin shot underway, WHO says
WHO's technical advisory group said it is reviewing data on India's Covaxin shot; decision on its emergency use listing is likely soon
"If all is in place and all goes well and if the committee is satisfied, we would expect a recommendation within the next 24 hours or so," Margaret Harris told journalists at a U.N. press briefing.
Millions of Indians have taken the shot produced by Bharat Biotech but many have been unable to travel pending the WHO approval.
The Economic Times Business News App for the Latest News in Business, Sensex, Stock Market Updates & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.